Background Studies of occupational acute mountain sickness (AMS) have not focused on the more severe end of the spectrum to date.
Introduction
Acute mountain sickness (AMS) is a common complication of hypobaric environmental stress [1, 2] . It can be associated with significant morbidity leading to compromise in both physical and cognitive functioning. AMS remains a persistent and even growing problem, despite decades of research into the factors that may influence its incidence and severity. Beyond the well-established AMS risk factors such as degree of elevation, rate of ascent to a given altitude [1] [2] [3] and level of exertion under hypobaric conditions [4] , the identification of other potentially modifiable variables remains elusive. Obesity and migraine history have been shown to impart AMS risk [5, 6] , but beyond that individual susceptibility is generally considered an idiosyncratic phenomenon [7] [8] [9] [10] .
Thus, risk profiling has focused on physiological characteristics of an AMS-prone state, such as excessive desaturation under hypobaric conditions, a low ventilatory response to exercise or variability in nitric oxide metabolism [4, 11] .
It is unclear whether certain established or suspected factors are associated with an increased risk of severe AMS. These factors include obesity, decrements in lung function, hypertension and previous less severe AMS episodes that have not led to chamber treatment. There is also a need to assess whether current cigarette smoking might be associated with AMS as smoking reduction is an achievable workplace wellness intervention. We have previously shown in a longitudinal analysis that a secondhand smoke exposure reduction policy that was successfully instituted at the mine site was temporally associated with improved lung function [12] . We, therefore, carried out this study to examine AMS risk through a retrospective analysis of cases in a population employed at high altitude.
Methods
Study data were extracted from the clinical illness case files and baseline hire and annual surveillance examination records of the occupational health service for an active gold mine operating at an altitude of 3800-4200 m. The mine is located in the Tyan Shan Mountains of the Kyrgyz Republic, ~400 km from its capital, Bishkek. This occupational cohort, provided a unique opportunity to study AMS. First, this is a relatively large cohort and AMS is an endemic problem in this setting. Second, there is a medical service at the mine allowing easy identification of people with symptoms of AMS and on-site use of a compression (hyperbaric) chamber for treatment of clinically severe cases. Finally, electronic medical records including premorbid surveillance data facilitated the identification of cases as well as the selection of matched referent mine workers without compression chamber-treated AMS, permitting a nested case-control study. Mineworkers generally work 2 week periods onsite, with a 12 hour on, 12 hour off shift schedule while at the mine. Mining personnel commute on buses from their places of permanent residence either in the Issykul Lake plateau area of Kyrgyzstan (1600 m elevation) or in Bishkek and its environs (700 m).
All mine employees undergo pre-placement and annual health surveillance screening in Bishkek, which provided the premorbid data for both cases and referents. Although screening does select out individuals based on the presence of selected health conditions, prior AMS events are not considered an employment exclusion criterion. The medical database includes all screening data and test results for each employee as well as records of any symptomatic mine clinic visits, with mandatory entry of an associated diagnosis code. This includes separate coding options for 'mountain sickness' (MS) and 'AMS'. Although distinct options, they are applied too interchangeably in practice to allow their use as separate distinct diagnostic entities for these purposes of this investigation.
We queried this database to identify all on-site mine clinic intake visits involving a diagnosis of MS or AMS during a period of 4 years, starting on 1 January 2009 and ending on 31 December 2012. The calendar year 2009 marked the introduction of the medical electronic software system. The MS or AMS codes are typically entered when employees present with complaints that are consistent with high-altitude syndromes and when another aetiology for such symptoms is not readily apparent.
Management of AMS cases is based on conventional assessment and management protocols, with cases designated as mild, moderate or severe [1, 2] . Symptoms that prompt the clinical diagnosis include persistent headache (especially with a poor response to acetaminophen [paracetamol] or ibuprofen), dizziness, shortness of breath, gastrointestinal complaints, sleep disturbance and fatigue. Suspected MS/AMS is generally treated empirically with acetazolamide 125 mg orally every 12 hours and with inhalation of supplementary oxygen for at least 30 minutes, following which the patient is reassessed clinically. In practice, systematic standard elicitation of complaints that could yield Lake Louise Scoring (LLS) is not recorded. This tool is a scoring system to assess the presence and severity of AMS, which quantifies headache with other symptoms of AMS [13] .
The occupational medicine clinic on-site at the mine is equipped with a fully functional multiplace hyperbaric chamber (Southern Oceanic, Republic of South Africa). Patients considered on clinical grounds to be suffering from severe AMS are treated in the chamber. We restricted the case definition of AMS to those persons who were deemed ill enough to undergo compression chamber treatment. We selected two referents for each case, one on each side of a numeric sorting by employee identification number. When annual surveillance data were missing (e.g. when that employee was no longer in the workforce), we selected the next listed employee. The mean time elapsed from the screening examination until the incident AMS event was 3.5 months among the cases and 4 months among the incidence density-matched referent employees.
Annual screening data closest in date prior to the event were used to derive demographics, place of permanent residence, physical examination and testing data and duration of employment. Clinical data included height and weight (yielding body mass index [BMI] ), blood pressure, findings of fundoscopic examination by a trained ophthalmologist (a routine in the surveillance protocol), pulmonary function test results (MicroLoop portable spirometer with Spida5 software, FusionCare, Hampshire, UK) and electrocardiogram (ECG) assessment. The cigarette smoking status of each mine employee is reassessed at every annual screening. Selfreported daily smoking at the time of examination and numbers of cigarettes smoked per day are elicited and further assessed with an exhaled carbon monoxide (CO) measurement by means of portable breath CO analyser (Smokerlyzer, Bedfont, UK).
Because the medical electronic record system did not cover the earlier period between hire and the years of our study, prior AMS events were identified through review of hard copy medical files. From this data source, the number and date of such episodes along with their severity and treatment were extracted. We excluded any potential referent with a record of prior chamber treatment: this had occurred in only one potential referent and an employee with the closest adjacent identification number was substituted. No previous chamber treatments were identified among the cases prior to the case-defining event.
We used logistic regression analysis to estimate the relative odds of severe AMS (defined by compression chamber treatment) using a hierarchical approach to model building. In the first step, we compared cases and referents in terms of two groups of variables: potential study confounders and potential risk factors of primary study interest (t-test, Fisher's exact test or 2*2 tables were used). For confounders, we assessed differences between cases and referents in age, sex and altitude of residence (because those dwelling at higher altitude might be protected from AMS). Among risk factors for disease, we were interested in obesity, lung function, hypertension or its sequelae, previous MS/ AMS and cigarette smoking. The latter was of particular interest because it is potentially modifiable at the workplace [12] . Moreover, in addition to self-reported smoking status, we also had exhaled CO measurements. The characteristics of cases and referents are shown in Table 1 . We limited logistic regression modelling only to those variables of primary study interest that differed between cases and referents (P < 0.20). We tested each of these in bivariate models and then in multivariate models adjusted for age, sex and place of residence (Issykul plateau versus Bishkek and its environs). We further explored the relationship between cigarette smoking and AMS, taking into account previous AMS events. To assess potential mediation and effect moderation, we tested these models with and without a prior AMS*smoking interaction term. These final models did not include sex, age and residence. The study protocol was reviewed and approved by the committee on bioethics of the Kyrgyz State Medical Academy. Table 1 , the study population was predominantly male, but females were over-represented among cases and cases were slightly younger than referents (P < 0.20, meeting criteria for model inclusion; see Methods). Most saliently, a substantially greater proportion of cases had experienced at least one prior episode of less severe AMS compared with referents (53% versus 7%; P < 0.001). Lung function parameters, blood pressure and BMI were similar among cases and referents. Resting heart rates were marginally faster among the cases compared with referents, but not at a level of statistical significance. Cigarette smoking status differed between cases and referents for each of the three measures studied: there were almost twice as many smokers in the case group, they smoked twice as many cigarettes per day and their exhaled CO level was higher compared with referents (Table 1) .
Results

MS
The clinical symptoms and treatment of the 15 cases of severe AMS are summarized in Table 2 . The most prevalent symptom group was neurological, with at least one of the following symptoms present: headache, dizziness or numbness of the extremities. Gastrointestinal and cardiopulmonary symptoms were less common. In accordance with standard recommendations [13] , all cases were treated with acetazolamide and systemic corticosteroids were administered in all but two. By study definition, all 15 cases underwent compression chamber treatment. None evolved into more serious disease requiring emergency transport to lower altitude (the protocol for high-altitude pulmonary oedema or highaltitude cerebral oedema).
Based on a priori criteria, we tested six independent variables as risk factors for AMS (based on their bivariate associations in Table 1 ; see Methods). These analyses are shown in Table 3 , which presents the unadjusted odds ratio (OR; consistent with the previous bivariate data) and then the OR adjusted for age, sex and place of residence. We chose to include age, sex and residence in the multivariate model because they were potential confounding variables. Work duration was negatively associated with severe AMS, while increased heart rate was positively associated, although neither factor was statistically significant in these models. In contrast, both previous AMS and current cigarette smoking (assessed dichotomously or by intensity) were associated with increased odds of severe AMS. Smoking adjusted for age, sex and place of residence increased the odds for severe AMS by 10 times, while any previous but less severe AMS increased odds by an even greater margin (Table 3) . Smoking, ascertained both by the number of cigarettes smoked per day and the concentration of exhaled CO, was tested in separate multivariate models included both AMS and an AMS*smoking interaction term for each of the smoking measures ( Table 4) . The interaction terms were not statistically significant in either model. Moreover, the effect estimates for cigarettes per day and exhaled CO were similar with (Model 2) or without the interaction term (Model 1) in the model, although the prior AMS effect estimate became less stable with inclusion of the interaction term.
Discussion
We found that active cigarette smoking was a potent risk factor for severe AMS. The cigarette smoking exposure-response was noted both for self-reported smoking quantities and exhaled CO and was robust even after taking into account any prior AMS event. Moreover, prior AMS risk, as anticipated and supporting our study methodology, was a powerful independent risk factor for recurrent AMS, consistent with the findings of other epidemiological investigations [3, 8, 10, [14] [15] [16] .
The chief focus in investigations of AMS risk has been on physiological variables that predispose to adverse outcomes, such as rate of ascent [14] [15] [16] [17] , obesity [5] , oxygen desaturation [9] and hypoxic tolerance [4] . One prospective cohort study of six different physiological measures (oxygen desaturation, low heart rate and low ventilator rate, each at rest and at exercise) found all predisposed to severe high-altitude-related illness [4] .
The potential importance of cigarette smoking in AMS varies with the population studied. Among mountain climbing enthusiasts, the prevalence of active cigarette smoking is generally low (e.g. 9% in one such study [8] and 11% in another study [15] ). Cigarette smoking is, however, much more common in occupational cohorts, tourists and military personnel assigned to high altitude. It is all the more notable, therefore, that two relatively large studies of cohorts in which smoking is common have found that this factor appears to be protective against AMS. One of these analysed nearly 400 railway construction workers in China, the highest worksite being at 4905 m [18] . Current smokers had lower LLS values for AMS compared with non-smokers, driven largely by headache symptoms, yet conversely, smoking was associated with lung function and oxygenation deficits at follow-up [18] . A second study from China found that for military recruits taken to a high altitude, cigarette smoking was also protective for LLS-defined AMS [19] . Several other studies of AMS have also reported an association suggestive of smoking being a protective factor for AMS, albeit not a statistically significant one [3, 4, 8, 15] . Other data on carboxyhaemoglobin or exhaled CO as a potential AMS risk derive from an interest in potential exposure to CO from cooking stoves in mountaineering. This has not been found to be associated with risk, positively or negatively [20] . Cigarette smoking is associated with lower exhaled NO [21] and may confound the association with AMS. The analysis of Chinese military recruits noted above paradoxically found higher pre-ascent exhaled NO among the cases, even though smokers had lower levels; no multivariate analysis was reported [19] . A key aspect of our study is that we defined AMS as episodes severe enough on clinical grounds to undergo compression chamber treatment. It may be that smoking protects against certain symptoms that contribute to LLS-defined illness but nonetheless conveys increased risk of more severe illness. In that light, we believe that our study's limitation of a lack of systematic LLS data is counterbalanced by its ability to identify cases at the severe end of the AMS disease spectrum. This also would explain the lack of a reduction in the risk associated with current smoking by prior, less severe AMS events when tested in the same model. Were smoking to be strongly associated with milder AMS, including such events on the multivariate modelling should have affected smoking-associated risk estimates.
Ours was a relatively small sample, comprising only 15 cases of severe AMS. Thus, we lack statistical power to detect modest associations (e.g. in the observed trends of lower forced expiratory volume in 1 second/ forced vital capacity and in heart rate). Even though there was no marked difference in occupation status of cases and referents when grouped broadly (production versus service work), we acknowledge that a far larger study would be needed to identify or exclude specific job tasks as risk factors for severe AMS. Our initial choice of variables beyond smoking was based on the findings of other studies. Most of the selected physiological variables were extracted from an annual screening prior to the event, a strength of the study, but the analysis was therefore limited in its range of selected variables. Inclusion of other variables might have identified additional associations that could not be studied in this study. Certain other factors simply cannot be studied in our working population (e.g. rate of ascent or number of nights at a given altitude before final ascent) because our subjects are all transported to the mine site by bus, a 7 hour trip. Symptom-driven bias in subjects' reports of their smoking status is not relevant as this was assessed prior to the AMS event. Treatment bias (selection for chamber treatment on the grounds not of illness severity but of clinical concern over smoking status) is unlikely and notably our analysis took place after the study period. Moreover, if smoking were simply a risk factor for occult lung disease that led to greater symptom severity we should have seen a stronger association with impaired lung function. Finally, this study involves intermittent high-altitude exposure in well-acclimatized workers and thus should not be generalized to others such as non-acclimatized non-occupational populations. Our analysis raises the question of whether an otherwise fit for duty employee who has had one or more episode of AMS should be targeted for additional measures to prevent recurrent and potentially more severe events. Interestingly, national legislation in Kyrgyzstan, which is otherwise fairly prescriptive in terms of mandated surveillance and even work restrictions, does not identify a prior AMS episode as a contraindication for employment. The potential advantages of workplacebased smoking cessation efforts are more obvious. Smoking cessation programmes should be a priority, particularly targeting those with prior AMS for additional efforts, given that effective smoking cessation strategies do exist [22] . This is no panacea however and middle-aged working populations without severe smoking complications may be one of the hardest in which to achieve successful cessation [23] .
In summary, this study demonstrates more severe AMS may be associated with some risk factors that are similar to and some that may differ from those for less severe AMS. In conditions of intermittent exposure in well-acclimatized workers, smoking appears to play a potent role in severe AMS, suggesting that in such populations effective smoking cessation measures may reduce AMS-associated morbidity.
Key points
• Severe acute mountain sickness requiring compression treatment may be associated with risk factors that differ from those for less severe sickness, in particular in terms of smoking-related risk.
• Pre-employment evaluation of prospective employees for high-altitude work should take into account previous acute mountain sickness and smoking, as both may identify individuals at higher risk.
• Work-based smoking cessation interventions for high-altitude employees should consider the potential added benefit of severe acute mountain sickness prevention. 
Given at a meeting of the Association on 3 April 1964
I am an Appointed Factory Doctor, but it was as a general practitioner that I received a Nuffield Travelling Fellowship for 1963. I had chosen to study the type and range of general practice and the place of the general practitioner in industry. I was also to consider what part the general practitioner could play in a future occupational health service in this country. The tour was started in July 1963 and most of the time was spent in two places-5 weeks in California and 11 weeks in Cincinnati. In North America there is a large and growing body of whole-time industrial physicians, and these are of a high order of knowledge and efficiency. They are the experts. For the greater part they are whole time employees of big industrial organizations. They are responsible for the running of their medical services and research, and set the standard of occupational health throughout the country.
A very comprehensive Workmen's Compensation system is really the basis of the greater part of the work of the general practitioner in industrial medicine, and it is at first sight of immense value in the creation of occupational health systems generally. Unfortunately, during its development the emphasis seems to have altered. The ideals, including fair reimbursement for suffering and loss of earnings, and early rehabilitation, have sometimes been submerged in the processes of preparing a case for presentation to the Accident Commission. The disability will be assessed most carefully-possibly using the standard Packard Thurber system-to achieve some uniformity. Compensation will be awarded strictly in accordance with a standard scale, taking into consideration the patient's age, the exact anatomical site of the lesion, the percentage of loss of movement and expectancy in that man's specific trade. With these tremendously detailed assessments, time is lost and it seemed to me that early and adequate rehabilitation was impeded. I was surprised at the wide range of disabilities accepted as industrial in origin and shocked at the amount of compensation awarded-for example, for bronchitis and coronary disease.
Undoubtedly the general practitioner has an established place in occupational health in the United States. It is, however, fairly limited in its application. Individual and group practitioners provide good casualty and routine examination services for large and small industries.
Although to us it is clearly desirable that all factories should have medical services, occupational health has not yet been completely sold to industry. There industrial medical practitioners dealing mainly with Workmen's Compensation cases have not established free access into plants, and they appear to have little enthusiasm for, or encouragement to be interested in, sick factories. Though splendid and growing centres for environmental studies are available there is much left to be achieved in terms of getting the proprietor or management to want medical services. Post-graduate training in the speciality is available, but on the whole poorly attended, and it would seem that though this must be made more attractive, the subject of occupational health ought to be a mandatory undergraduate subject. 
